• Matica Biotechnology Breaks Ground on Cell and Gene Therapy Site contractpharma
    March 04, 2021
    ​Matica Biotechnology, a contract development and manufacturing organization (CDMO) specializing in the clinical and commercial production of cell and gene therapies, broke ground on its new 25,000 square foot facility which will house its GMP virus ...
PharmaSources Customer Service